Judy Krandel Power - 16 Mar 2026 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Chief Financial Officer
Signature
/s/ Christopher Melsha as attorney-in-fact for Judy Krandel pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 16:17:19 UTC
Previous filing
07 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Krandel Judy Chief Financial Officer 380 LACKAWANNA PLACE, SOUTH ORANGE /s/ Christopher Melsha as attorney-in-fact for Judy Krandel pursuant to power of attorney previously filed. 18 Mar 2026 0001668351

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (right to buy) Award +4,000 $0.000000* 4,000 16 Mar 2026 Common Stock 4,000 $2.92 Direct F3
holding NEPH Stock Option (right to buy) 122,524 16 Mar 2026 Common Stock 122,524 $1.71 Direct F1
holding NEPH Stock Option (right to buy) 54,359 16 Mar 2026 Common Stock 54,359 $1.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to purchase 30,631 shares vest on 11/1/24 and options to purchase the remaining 91,893 shares vest quarterly in 12 equal amounts commencing on 2/1/2025.
F2 Options to purchase 13,589 shares vest on 3/27/2026 and options to purchase the remaining 40,770 shares vest quarterly in 12 equal amounts commencing on 6/27/2026.
F3 Options to purchase 1,000 shares vest on 3/16/2027 and options to purchase the remaining 3,000 shares vest quarterly in 12 equal amounts commencing on 6/16/2027.